Article
Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 10 Jun 2013
Marcucci Guido, Maharry Kati S, Metzeler Klaus H, Volinia Stefano, Wu Yue-Zhong, Mrózek Krzysztof, Nicolet Deedra, Kohlschmidt Jessica, Whitman Susan P, Mendler Jason H, Schwind Sebastian, Becker Heiko, Eisfeld Ann-Kathrin, Carroll Andrew J, Powell Bayard L, Kolitz Jonathan E, Garzon Ramiro, Caligiuri Michael A, Stone Richard M, Bloomfield Clara D
Abstract excerpt
PURPOSE: To evaluate the impact of miR-155 on the outcome of adults with cytogenetically normal (CN) acute myeloid leukemia (AML) in the context of other clinical and molecular prognosticators and to gain insight into the leukemogenic role of this microRNA. PATIENTS AND METHODS: We evaluated 363...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
